USC Today

Lisa Welter

Expert in the characterization of disease evolution and treatment resistance through CTCs and cfDNA in patients with HR+ metastatic breast cancer
  • PhD Candidate in Molecular Biology; CSI Cancer; The Michelson Center
  • USC Dornsife College of Letters, Arts and Sciences
Links:

Expertise

  • Circulating Tumor Cells (CTCs)
  • Liquid biopsy
  • Cell-free DNA (cfDNA)
  • Circulating Tumor DNA (ctDNA)
  • Precision Oncology
  • Personalized Medicine
  • Single Cell Genomics
  • Next-Generation Sequencing
  • Copy Number Alterations
  • Single Nucleotide Variations
  • Plasma, Blood
  • Cancer Research
  • Breast Cancer
  • Tumor Evolution
  • Multi-omics

Languages

  • English
  • German
  • Dutch

Additional Information

  • Archer
  • Vice-President of Molecular Biology Graduate Student Association (MBGSA)